314 Action Statement Ahead of RFK Jr.’s Peptide Advisory Hearing

“RFK Jr. has turned MAHA moms into lab rats”

(Philadelphia, Pennsylvania) — Tomorrow, the Food and Drug Administration (FDA)’s Pharmacy Compounding Advisory Committee (PCAC) will begin a two-day public hearing to decide whether to loosen restrictions on “trendy peptide therapies,” which Robert F. Kennedy Jr. supports—and uses himself. Ahead of the hearings, 314 Action President Shaughnessy Naughton released the following statement:  

“RFK Jr. has turned MAHA moms into lab rats. Americans deserve and expect that FDA approved treatments have been rigorously tested and proven to be safe and effective. Cutting corners to approve “miracle drugs” favored by the Secretary is not gold standard science. The data doesn’t exist. RFK Jr. has reshaped the FDA’s panel with foot soldiers who will financially benefit from weaker peptide restrictions. But the simple fact remains—there has never been a large-scale, rigorous human trial on the long-term effects of peptides.

“The hypocrisy from RFK Jr. is stunning. He’s made it HHS’ mission to discredit decades of proven research showing childhood vaccines are safe and effective, but wants to experiment with untested, unproven nutraceuticals and unleash them on the American people. This is a continuation of a disturbing pattern—RFK Jr. is once again putting his personal beliefs and pet projects ahead of public health. Even if the PCAC recommends loosening restrictions, 314 Action urges the FDA to reject their recommendation and commit to further research on their effects.” 

Read 314 Action’s fact sheet on RFK Jr. and peptides. 

###

314 Action is the only national organization working to recruit, train and elect Democratic scientists across all levels of government—from the Senate down to local school boards. The organization is powered by a grassroots community of over six million people supporting scientists and health care professionals who will use science and facts to address the most urgent issues facing our generation.